神州细胞
(688520)
| 流通市值：187.49亿 | | | 总市值：198.01亿 |
| 流通股本：4.45亿 | | | 总股本：4.70亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 323,190,678.39 | 1,560,152,996.71 | 1,311,881,128.84 | 972,020,482.48 |
| 营业收入 | 323,190,678.39 | 1,560,152,996.71 | 1,311,881,128.84 | 972,020,482.48 |
| 二、营业总成本 | 472,019,007.38 | 2,075,196,015.13 | 1,491,402,986.03 | 987,045,730.66 |
| 营业成本 | 33,718,805.2 | 107,677,220.44 | 77,530,046.99 | 50,672,182.64 |
| 税金及附加 | 2,515,188.29 | 13,405,900.94 | 10,387,466.23 | 6,952,661.84 |
| 销售费用 | 196,959,180.82 | 843,076,444.55 | 628,510,651.19 | 421,692,188.2 |
| 管理费用 | 45,651,187.27 | 187,212,281.06 | 124,665,441.74 | 85,399,687.34 |
| 研发费用 | 171,395,414.91 | 837,852,488.89 | 581,824,568.34 | 378,953,532.38 |
| 财务费用 | 21,779,230.89 | 85,971,679.25 | 68,484,811.54 | 43,375,478.26 |
| 其中:利息费用 | 21,882,614.89 | 83,830,964.16 | 65,898,999.41 | 41,951,607.02 |
| 其中:利息收入 | -469,276.15 | 1,881,707.65 | 1,407,568.62 | 949,103.75 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -1,084,047.81 | 10,323,313.36 | 14,081,917.44 | 14,590,195.22 |
| 加:投资收益 | 533,238.55 | 1,253,907.51 | 734,251.04 | 366,004.48 |
| 资产处置收益 | - | 5,814.16 | - | - |
| 资产减值损失(新) | -7,872,216.39 | -19,642,764.22 | -11,836,997.31 | -11,524,437.59 |
| 信用减值损失(新) | 4,031,475.03 | -4,823,022.32 | -6,268,772.81 | -6,622,082.22 |
| 其他收益 | 4,579,895.53 | 91,576,709.54 | 16,721,120.17 | 11,670,658.06 |
| 四、营业利润 | -148,639,984.08 | -436,349,060.39 | -166,090,338.66 | -6,544,910.23 |
| 加:营业外收入 | 17,215.4 | 100,222,129.08 | 100,036,158.09 | 100,027,150.44 |
| 减:营业外支出 | 32,953,177.12 | 227,494,426.06 | 185,225,421.1 | 127,340,391.5 |
| 五、利润总额 | -181,575,945.8 | -563,621,357.37 | -251,279,601.67 | -33,858,151.29 |
| 减:所得税费用 | -291,970.86 | 2,580,828.34 | - | - |
| 六、净利润 | -181,283,974.94 | -566,202,185.71 | -251,279,601.67 | -33,858,151.29 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -181,283,974.94 | -566,202,185.71 | -251,279,601.67 | -33,858,151.29 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -175,685,454.77 | -564,852,296.49 | -250,672,332.75 | -33,771,096.29 |
| 少数股东损益 | -5,598,520.17 | -1,349,889.22 | -607,268.92 | -87,055 |
| 扣除非经常损益后的净利润 | -147,501,663.75 | -545,373,538.18 | -200,303,428.99 | -36,108,173.65 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.41 | -1.32 | -0.6 | -0.1 |
| (二)稀释每股收益 | -0.41 | -1.32 | -0.6 | -0.1 |
| 八、其他综合收益 | -772,094.69 | 134,911.37 | 92,768.44 | 268,031.28 |
| 归属于母公司股东的其他综合收益 | -746,847.19 | 134,574.09 | 92,536.52 | 267,361.2 |
| 九、综合收益总额 | -182,056,069.63 | -566,067,274.34 | -251,186,833.23 | -33,590,120.01 |
| 归属于母公司股东的综合收益总额 | -176,432,301.96 | -564,717,722.4 | -250,579,796.23 | -33,503,735.09 |
| 归属于少数股东的综合收益总额 | -5,623,767.67 | -1,349,551.94 | -607,037 | -86,384.92 |
| 公告日期 | 2026-04-30 | 2026-04-23 | 2025-10-31 | 2025-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |